Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057850
Status:
COMPLETED
Last Update Posted:
2013-02-11
First Post:
2003-04-07
Brief Title:
BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV salivary gland cancer | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| recurrent salivary gland cancer | View |
| salivary gland squamous cell carcinoma | View |